Topicus

By default your notes are visible only to you.

2.0

52-week range

4.8

4.69

Your model inputs

Required return / cost of capital

FCFF terminal growth rate

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Valuation

Free Cash Flow Yield

FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per share

(0.6) %

Dividend Yield TTM

Market cap $

$ 468.9

Price / Earnings TTM

P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per share

(13.4)

Price / Book TTM

(293.2)

PEG TTM

Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rate

(0.6)

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

46.1 %

(52.5) %

(51.6) %

Free cash flow per share growth

92.6 %

(159.2) %

Earnings per share growth

23.9 %

(125) %

Founded: 1,998

Employees: 800

Business Summary:The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.

Fair Value Reference Estimate